Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
CUE
$34.20
+10.04%
CUE · Cue Biopharma, Inc.
$34.20
+3.12 (+10.04%)
At close · Aug 14
Going-concern doubt
— cleared Aug 14, 2026
The latest filing no longer states the doubt (first flagged May 14, 2026).
View the 10-Q filed Aug 14, 2026Market Cap
$248.44M
Shares
7.26M
All earnings calls
Earnings call · FY2024 Q4
Cue Biopharma, Inc. Q4 FY2024 Earnings Call
Cue Biopharma, Inc. Q4 FY2024 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
$1.58M
-13.5% YoY
Net income · derived Q4
-$9.50M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 31, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 31, 2025 · complete as-filed document